Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18.

Tanaka, F

Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18. [electronic resource] - Gene therapy Nov 2002 - 1480-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0969-7128

10.1038/sj.gt.3301827 doi


Adenosarcoma--therapy
Adenoviridae--genetics
Animals
Dendritic Cells--immunology
Fas Ligand Protein
Fibrosarcoma--immunology
Genetic Therapy--methods
Genetic Vectors--administration & dosage
Immunotherapy, Adoptive--methods
Injections, Intralesional
Interleukin-12--genetics
Interleukin-18--genetics
Membrane Glycoproteins--genetics
Mice
Mice, Inbred C57BL
Mice, Mutant Strains
Neoplasm Transplantation
T-Lymphocytes, Cytotoxic--immunology
Tumor Cells, Cultured